 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Comparison of Netarsudil/Latanoprost Therapy with Latanoprost Monotherapy for Lowering Intraocular Pressure: A Systematic Review and Meta-analysis |
| Jong-Wook Lee, Hyeon-Soo Ahn, Jinho Chang, Hye-Young Kang, Dong-Jin Chang, Jae Kyung Suh, Hankil Lee |
|
Korean J Ophthalmol. 2022;36(5):423-434. Published online August 19, 2022 DOI: https://doi.org/10.3341/kjo.2022.0061 |
|
Comparison of Netarsudil/Latanoprost Therapy with Latanoprost Monotherapy for Lowering Intraocular Pressure: A Systematic Review and Meta-analysis Korean Journal of Ophthalmology. 2022;36(5):423-434  PSS4 A Cost Effectiveness Analysis of Latanoprost Monotherapy, Netarsudil Monotherapy and Fixed Dose Combination Latanoprost/Netarsudil in Management of Primary Open Angle Glaucoma in USA Value in Health. 2021;24:S220-S221 Systematic Review of Intraocular Pressure-Lowering Effects of Adjunctive Medications Added to Latanoprost Ophthalmic Research. 2009;42(2):99-105 Bimatoprost versus latanoprost in lowering intraocular pressure in glaucoma and ocular hypertension: Results from parallel-group comparison trials Advances in Therapy. 2004;21(4):247-262 Mirtogenol® potentiates latanoprost in lowering intraocular pressure and improves ocular blood flow in asymptomatic subjects Clinical Ophthalmology. 2010;471 Efficacy and safety of netarsudil/latanoprost fixed-dose combination vs. monotherapy in open-angle glaucoma or ocular hypertension: A systematic review and meta-analysis of randomized controlled trials Frontiers in Medicine. 2022;9: Comparison of additional intraocular pressure-lowering effects of latanoprost vs brimonidine in primary open-angle glaucoma patients with intraocular pressure uncontrolled by timolol–dorzolamide combination Eye. 2004;19(2):145-151 Latanoprost/latanoprost/netarsudil Reactions Weekly. 2022;1903(1):219-219 Comparison of the Intraocular Pressure Lowering Effect of Latanoprost and Carteolol-pilocarpine Combination in Newly Diagnosed Glaucoma Japanese Journal of Ophthalmology. 2003;47(1):72-76 The additive intraocular pressure-lowering effect of latanoprost in combined therapy with other ocular hypotensive agents Survey of Ophthalmology. 1997;41:S93-S98 |
